Higher production of rabies virus in serum-free medium cell cultures on microcarriers

被引:42
作者
Frazzati-Gallina, NM
Paoli, RL
Mourao-Fuches, RM
Jorge, SAC
Pereira, CA
机构
[1] Inst Butantan, Lab Imunol Viral, BR-05503900 Sao Paulo, Brazil
[2] Inst Butantan, Lab Raiva, BR-05503900 Sao Paulo, Brazil
基金
巴西圣保罗研究基金会;
关键词
serum-free medium; VERO cells; rabies vaccine; microcarriers;
D O I
10.1016/S0168-1656(01)00362-5
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Rabies virus suspensions were obtained from VERO cells cultivated on solid microcarriers in a bioreactor after infection with the Pasteur rabies virus strain (PV). Virus production-serum free medium (VP-SFM) or Leibovitz 15 (L15) medium supplemented or not with fetal calf serum (FCS) were used to cultivate the VERO cells, before and after virus infection. The cell growth was shown to reach higher densities (1.6 x 10(6) cells mol 1), when VP-SFM supplemented with 1%. of FCS was used during the cell growth phase of culture, and then replaced by VP-SFM alone for the virus multiplication phase. In the cultures performed from the beginning with VP-SFM, lower densities accompanied by an altered cell morphology and detachment from the microcarriers were always observed. In rabies virus infected cultures, kinetic studies showed that higher virus yields (10(4.7) FFD50 per 0.05 ml) were always obtained in cultures performed initially on VP-SFM supplemented with 1% FCS and after infection on VP-SFM alone. In agreement with that, rabies virus production, as measured by the average of virus titers in harvests obtained at different times after infection were shown to be 5.5 times higher in the cell cultures using initially VP-SFM + 1%FCS and, following infection. VP-SFM alone. Besides the advantages of using media with a well-controlled composition, these data indicate the usefulness of serum free media also in terms of virus productivity. (C) 2001 Elsevier Science B.V. All rights reserved
引用
收藏
页码:67 / 72
页数:6
相关论文
共 32 条
[1]  
BARNGROVER D, 1985, J CELL SCI, V78, P173
[2]  
Beale A. J., 1992, V5, P189
[3]  
Berry JM, 1999, BIOTECHNOL BIOENG, V62, P12, DOI 10.1002/(SICI)1097-0290(19990105)62:1<12::AID-BIT2>3.0.CO
[4]  
2-G
[5]   FORMATION OF BRIDGES AND LARGE CELLULAR CLUMPS IN CHO-CELL MICROCARRIER CULTURES - EFFECTS OF AGITATION, DIMETHYL-SULFOXIDE AND CALF SERUM [J].
BORYS, MC ;
PAPOUTSAKIS, ET .
CYTOTECHNOLOGY, 1992, 8 (03) :237-248
[6]   Application of a serum-free medium for the growth of vero cells and the production of reovirus [J].
Butler, M ;
Burgener, A ;
Patrick, M ;
Berry, M ;
Moffatt, D ;
Huzel, N ;
Barnabé, N ;
Coombs, K .
BIOTECHNOLOGY PROGRESS, 2000, 16 (05) :854-858
[7]  
Gallina Neuza M. Frazatti, 1998, Revista do Instituto de Medicina Tropical de Sao Paulo, V40, P291, DOI 10.1590/S0036-46651998000500005
[8]   Improved titers of retroviral vectors from the human FLYRD18 packaging cell line in serum- and protein-free medium [J].
Gerin, PA ;
Gilligan, MG ;
Searle, PF ;
Al-Rubeai, M .
HUMAN GENE THERAPY, 1999, 10 (12) :1965-1974
[9]   Development of a mammalian cell (Vero) derived candidate influenza virus vaccine [J].
Kistner, O ;
Barrett, PN ;
Mundt, W ;
Reiter, M ;
Schober-Bendixen, S ;
Dorner, F .
VACCINE, 1998, 16 (9-10) :960-968
[10]  
Lorenz R. J., 1973, Laboratory techniques in rabies. WHO Monograph Series No.23., P321